Medication info
Cansatar Tablet 8 mg (Candesartan Cilexetil)

Cansatar Tablet 8 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›8mg / 1 tablet
Manufacturer / importer
Kyung Dong Pharmaceutical Co., Ltd.
Appearance
Light pink tablets that are round and convex on both sides with a dividing line on one side.
Packaging
30 tablets/bottle, 100 tablets (10 tablets/PTP x 10) (for export)
Approval status
Active

MFDS item code 201101018 · Notified 2011.02.28 · Insurance code 648103000

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, other treatment options should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No initial dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose is doubled at intervals of at least 2 weeks and may be increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Kyung Dong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • reduced left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension, effectively lowering blood pressure to protect blood vessels and the heart. It is also used among heart failure patients with impaired left ventricular systolic function who require additional treatment with ACE inhibitors or who are intolerant to ACE inhibitors. Thus, it helps reduce the burden on the heart and improve function, thereby enhancing cardiovascular health in patients through blood pressure control and heart failure treatment.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure remains uncontrolled at this dose, other treatment options should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly patients: No initial dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose is doubled at intervals of at least 2 weeks and may be increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus during pregnancy, so use must be discontinued immediately if pregnancy is confirmed. It should not be used by individuals with a known allergy to this drug or its components, pregnant women, nursing mothers, patients with severe liver dysfunction, or those with certain genetic disorders. Elderly patients, patients with hyperkalemia, liver disease, heart valve disease, and kidney disease should use this medication cautiously and must have regular blood and renal function tests. Common side effects include dizziness, back pain, and respiratory infections, while severe cases may result in hypotension, worsening renal function, blood disorders, and liver dysfunction; if symptoms occur, immediate consultation with a physician is necessary. Particular caution is needed for heart failure patients, kidney transplant patients, and dialysis patients when administering this medication, with necessary drug dosage adjustments and monitoring of conditions. Using this medication with other antihypertensives may increase its effects, so any current medications must be disclosed to healthcare providers. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers should avoid it or cease breastfeeding. The safety and efficacy in children and adolescents under 18 years have not been established, hence it is not recommended for such use. Elderly patients carry a risk of stroke due to excessive blood pressure lowering and should use this medication with caution. In case of overdose, symptoms such as hypotension, dizziness, and tachycardia may appear, requiring immediate medical attention. This medication should be kept out of the reach of children and should not be transferred to other containers for safety.

Side effects

  • Dizziness
  • low back pain
  • respiratory infections
  • upper respiratory infections
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 71 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • joint pain
  • proteinuria
  • weakness
  • fever
  • sensory disturbances
  • indigestion
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyperkalemia
  • hyponatremia
  • hypoglycemia
  • asthenia
  • hunger
  • cold sweats
  • hand tremors
  • decreased concentration
  • convulsions
  • consciousness disorders
  • intestinal vascular edema
  • elevated liver enzymes
  • hepatitis
  • liver dysfunction
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • kidney damage
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paresis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • dry mouth
  • sleep disorders
  • decreased libido
  • amnesia
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disorders
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air or moisture from entering. It should be stored at room temperature between 1 and 30 degrees Celsius for safe preservation. This way, the drug's effectiveness may be maintained and deterioration avoided.

Appearance and packaging

Appearance

Light pink tablets that are round and convex on both sides with a dividing line on one side.

Package unit

30 tablets/bottle, 100 tablets (10 tablets/PTP x 10) (for export)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.